Oncotarget On A Mission To Eradicate Disease

Oncotarget is a traditional multidisciplinary journal. It publishes online papers in weekly issues. Special demand for any paper or issue can be printed. The Journal aims to avail scientific results very fast and extensively available. It seeks to make the most of the research impact through intuitive review and to enable rapid sharing of exceptional discoveries. The journal is committed to removing the border that exists between specialties and to connect various fields of biomedical science. It also seeks to promote applications of clinical and basic science to battle the disease. Oncotarget educates people on different issues regarding oncology and lets them know of any recent research results.

The journal has been in operation since 2010. It has been able to expand and grow. This has led to the introduction of new sections beyond oncology. The Journal on Facebook states that their ultimate goal is to see people living lives without diseases. All researchers are allowed by the journal to give their contributions towards the progress of science. The word “Oncotarget” covers all cellular functions that are familiar with aging, cancer, molecules, cancer cells, neurodegeneration, lymphocytes, atherosclerosis, neurons, and microbes. The journal is currently giving Altmetric Article reports on scijournal.org free as part of their new journal platform that is providing instantaneous article coverage trafficking in traditional and digital media outlets.

Gregg L. Semenza and William G. Kaelin, Jr. are members of Oncotarget’s Editorial Board on bioxbio.com. They won the Lasker Award due to the discovery of the Oxygen-Sensing Pathway in 2016. The Journal has published over 370 papers on the topics related to oxygen since it was started in 2010. The Journal now allows articles and is publishing other subjects apart from Oncology. These include Endocrinology, Aging, Gerotarget, Microbiology, Immunology, Neuroscience, neuropathology, Metabolism, Cardiology, all areas of Pharmacology, and Cell Biology.

Andrei V. Gudkov and Mikhail Blagosklonny are the current editors-in-chief at Oncotarget. Gudkov works at the Roswell Park Cancer Institute. Impact Journals publishes all issues of Oncotarget. The journal attributes its success to good leadership and the hard work of all researchers who ensure they submit high-quality work with reliable results. Oncotarget is the Journal to visit for those seeking to understand all aspects of oncology.

Reference: http://endnote.com/downloads/style/oncotarget

One thought on “Oncotarget On A Mission To Eradicate Disease

  1. It will give you the in-depth knowledge you require while delivering the latest news in the world of science. The journal firmly believes that it will achieve its ultimate goal of people living in a free disease world. There are cases where essay writing service do have enough of this thing for them to succeed and to ensure that everything works well for them all.

Comments are closed.